StockpollyBeta
Get App
Delisting riskPopularity #4,570
RDHL · NASDAQ · Drug Manufacturers - Specialty & Generic

RedHill Biopharma (ADR) (RDHL)

Specialty biopharmaceutical developer behind Talicia and a partner-led oral-medicine pipeline.

$0.5304
vs last close−0.01 (−1.96%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

3.14M ADS as of Sep 16, 2026 · holders as of their latest filing

The share count is from the company's Dec 2023 annual report; nothing newer is on file here.

Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.

13F · 13D/G · Form 4

HolderStakeSharesDate
Alumni Capital LPInstitution
11.75%369,373filed Oct 20, 2025
683 Capital Management, LLCInstitution
—3.60% of class, as filed—filed Feb 13, 2020
Dror Ben-Asher1Insiderdirector, officer: Chief Executive Officer
——filed Mar 18, 2026
Shmuel Cabilly1Insiderdirector
——filed Mar 18, 2026
Cosmo Technologies Ltd.Strategic
—13.20% of class, as filed—filed Mar 7, 2022
EMC2 Fund Ltd.Strategic
—11.87% of class, as filed—filed Jan 6, 2017
Empery Asset Management, LPInstitution
—6.12% of class, as filed—filed Jan 13, 2023
First Investments Holding LtdStrategic
—18.40% of class, as filed—filed Feb 19, 2019
Adi Frish1Insiderofficer: Chief Corp & BD Officer
——filed Mar 18, 2026
Guy Joel Goldberg1Insiderofficer: Chief Business Officer
——filed Mar 18, 2026
Heights Capital Management, Inc.Strategic
—5.90% of class, as filed—filed Feb 1, 2024
Razi Ingber1Insiderofficer: Chief Financial Officer
——filed Mar 18, 2026
Investment Holdings LLCStrategic
—0.30% of class, as filed—filed Jan 27, 2022
Kevin KotlerInsider
—2.15% of class, as filed—filed Feb 10, 2017
Roni Mamluk1Insiderdirector
——filed Mar 18, 2026
Migdal Insurance & Financial Holdings LtdStrategic
—4.76% of class, as filed—filed Dec 29, 2016
Mitchell P. KopinInsider
—4.00% of class, as filed—filed Feb 2, 2024
OrbiMed Israel GP Ltd.Strategic
—4.88% of class, as filed—filed Feb 13, 2017
Gilead Raday1Insiderofficer: Chief Operating Officer
——filed Jul 13, 2026
Kenneth Reed2Insiderdirector
0.00%0filed Mar 18, 2026
Rick D. Scruggs1Insiderdirector, officer: Chief Commercial Officer
——filed Mar 18, 2026
Ofer Tsimchi1Insiderdirector
——filed Mar 19, 2026
YA II PN, Ltd.Strategic
—9.90% of class, as filed—filed Dec 23, 2025
  1. This position is filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
  2. Kenneth Reed reports a block also reported by Shmuel Cabilly; it is counted once, under Shmuel Cabilly.

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Alumni Capital LP9.99%369.4K13GOct 20, 2025
YA II PN, Ltd.9.90%508.7K13GDec 23, 2025

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jul 10, 2026
Gilead Radayofficer: Chief Operating Officer
Sale14,130,000$0.0001218,780,000
Apr 6, 2026
Gilead Radayofficer: Chief Operating Officer
Sale15,740,000$0.0001261,060,000

House and Senate disclosures

Not reported.